Given these findings, we plan to examine the SLC19A1 expression and phosphorylation of Akt in tumor tissues from NSCLC patients before and after PEM treatment to evaluate the effects that such factors have on clinical efficacy. Here, SLC19A1 is linked to non-small cell lung carcinoma.